PCM
COLL icon

Pentwater Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Pentwater Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100,000
Closed -$1.78M – 140
2015
Q2 		$1.78M Buy
+100,000
New +$1.73M 0.01% 146

Other funds holding COLL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pentwater Capital Management's COLL Position: Q3 2015 in Review

Pentwater Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2015, closing a stake of 100,000 shares — an estimated $1.78M sold.

Pentwater Capital Management first reported a position in COLL in Q2 2015 and held it in 1 quarter. The position peaked at $1.78M in Q2 2015. 49 funds tracked by Wall St. Rank hold COLL as of Q3 2015.

  • Pentwater Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2015 after selling out during the quarter.
  • Pentwater Capital Management sold 100,000 Collegium Pharmaceutical shares in Q3 2015, an estimated $1.78M.
  • Pentwater Capital Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 1 quarter.
  • Pentwater Capital Management's Collegium Pharmaceutical position peaked at $1.78M in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2015.

Based on Pentwater Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.